Few major developments today (CNBC interview)
- Received emergency use approval from DCGI for use of Pegylated Interferon alpha-2b, ‘Virafin’ in treating moderate COVID-19 infection in adults
- Current vaccine capacity is 1-1.2 cr. doses/month. Looking to double the capacity in next 3-4 months
- Final endpoint data should come by May after which they will apply for emergency use authorization
- Can repurpose vaccine for South African and other variants
Update: Useful management interview with ET about their drug approval
https://www.youtube.com/watch?v=p66G8aHG-d4
Disclosure: Invested (position size here)